Comparison of epoetin alfa (EPO) and darbepoetin alfa (DARB) utilization in cancer chemotherapy patients treated in a hospital outpatient setting

被引：0

|

作者：

Vekeman, F.

LaFeuille, M.

Bailey, R.

Piech, C. Tak

McKenzie, R. S.

Lefebvre, P.

机构：

[1] Grp Analyse Ltd, Montreal, PQ, Canada

[2] Centocor Ortho Biotech Serv LLC, Horsham, PA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e17524

引用

收藏

页数：1

相关论文

共 50 条

[41] Comparable results seen with darbepoetin and epoetin alfa in breast cancer patients
不详
[J]. ONCOLOGY-NEW YORK, 2005, 19 (03): : 368 - +
[42] Comment: Epoetin alfa versus darbepoetin alfa for cancer patients with treatment-related anemia - Reply
Cersosimo, RJ
Jacobson, DR
[J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (05) : 999 - 999
[43] Clinical benefits and risks associated with darbepoetin alfa and epoetin alfa treatment in patients with lung cancer and chemotherapy-induced anemia.
Tiotiu, Angelica
Clerc-Urmes, Isabelle
Chabot, Francois
Martinet, Yves
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[44] The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia
Ben-Hamadi, R
Duh, MS
Aggarwal, J
Henckler, A
McKenzie, RS
Piech, CT
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (10) : 1677 - 1682
[45] Head-to-head comparison of epoetin alfa (EPO) 40,000 U QW vs darbepoetin alfa (DARB) 200 μg Q2W in anemic cancer patients receiving chemotherapy (CT):: Final results of a planned interim analysis (IA)
Waltzman, R
Williams, D
[J]. BLOOD, 2004, 104 (11) : 144B - 144B
[46] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTS
Lafeuille, M. H.
Bailey, R. A.
Senbetta, M.
McKenzie, R. S.
Lefebvre, P.
[J]. VALUE IN HEALTH, 2011, 14 (03) : A160 - A160
[47] A randomized comparison of darbepoetin alfa every three weeks with epoetin thrice weekly for chemotherapy induced anemia in nonhematological cancer patients
Kotsori, A. A., Jr.
Vaslamatzis, M. M.
Alexopoulos, C. G.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[48] A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia
Steensma, David P.
Dakhil, Shaker R.
Novotny, Paul J.
Sloan, Jeff A.
Johnson, David B.
Anderson, Daniel M.
Mattar, Bassam I.
Moore, Dennis F., Jr.
Nikcevich, Daniel
Loprinzi, Charles L.
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) : 877 - 881
[49] Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 μg every 2 weeks) in anemic patients with cancer receiving chemotherapy
Waltzman, R
Croot, C
Justice, GR
Fesen, MR
Charu, V
Williams, D
[J]. ONCOLOGIST, 2005, 10 (08): : 642 - 650
[50] A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer
Schwartzberg, LS
Yee, LK
Senecal, FM
Charu, V
Tomita, D
Wallace, J
Rossi, G
[J]. ONCOLOGIST, 2004, 9 (06): : 696 - 707

← 1 2 3 4 5 →